Literature DB >> 33303932

Failure of first anti-tau antibody in Alzheimer disease highlights risks of history repeating.

Asher Mullard.   

Abstract

Entities:  

Year:  2021        PMID： 33303932     DOI： 10.1038/d41573-020-00217-7

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  14 in total

1.  Does the Anti-Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? Yes.

Authors:  Alberto J Espay; Kariem Ezzat; Andrea Sturchio
Journal:  Mov Disord Clin Pract       Date:  2021-08-31

2.  Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force.

Authors:  P S Aisen; R J Bateman; M Carrillo; R Doody; K Johnson; J R Sims; R Sperling; B Vellas
Journal:  J Prev Alzheimers Dis       Date:  2021

Review 3.  Disease-specific interactome alterations via epichaperomics: the case for Alzheimer's disease.

Authors:  Stephen D Ginsberg; Thomas A Neubert; Sahil Sharma; Chander S Digwal; Pengrong Yan; Calin Timbus; Tai Wang; Gabriela Chiosis
Journal:  FEBS J       Date:  2021-06-12       Impact factor: 5.622

4.  Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer's disease and the role of glial cells.

Authors:  Yanpan Gao; Jiaqi Liu; Jiayu Wang; Yifan Liu; Ling-Hui Zeng; Wei Ge; Chao Ma
Journal:  Brain Pathol       Date:  2022-01-11       Impact factor: 7.611

Review 5.  Positron Emission Tomography in Animal Models of Tauopathies.

Authors:  Lei Cao; Yanyan Kong; Bin Ji; Yutong Ren; Yihui Guan; Ruiqing Ni
Journal:  Front Aging Neurosci       Date:  2022-01-10       Impact factor: 5.750

Review 6.  Delivery of Intravenously Administered Antibodies Targeting Alzheimer's Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis.

Authors:  Toshihiko Tashima
Journal:  Pharmaceutics       Date:  2022-02-14       Impact factor: 6.321

7.  Fallacies in Neuroscience: The Alzheimer's Edition.

Authors:  Karl Herrup
Journal:  eNeuro       Date:  2022-02-10

Review 8.  Immunotherapy for Alzheimer's disease: targeting β-amyloid and beyond.

Authors:  Chenghuan Song; Jiyun Shi; Pingao Zhang; Yongfang Zhang; Jianrong Xu; Lanxue Zhao; Rui Zhang; Hao Wang; Hongzhuan Chen
Journal:  Transl Neurodegener       Date:  2022-03-18       Impact factor: 8.014

Review 9.  Magnetic Resonance Imaging in Tauopathy Animal Models.

Authors:  Ruiqing Ni
Journal:  Front Aging Neurosci       Date:  2022-01-25       Impact factor: 5.750

Review 10.  Prospects of Marine Sterols against Pathobiology of Alzheimer's Disease: Pharmacological Insights and Technological Advances.

Authors:  Md Ataur Rahman; Raju Dash; Abdullah Al Mamun Sohag; Mahboob Alam; Hyewhon Rhim; Hunjoo Ha; Il Soo Moon; Md Jamal Uddin; Md Abdul Hannan
Journal:  Mar Drugs       Date:  2021-03-20       Impact factor: 5.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.